Leah Rush

Stock Analyst at Brookline Capital

(2.55)

# 2,140

Out of 5,179 analysts

2

Total ratings

100%

Success rate

26.48%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Leah Rush

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CCCC C4 Therapeutics	Maintains: Buy	$20 → $30	$2.41	+1,144.81%	1	Feb 23, 2026
	EXEL Exelixis	Initiates: Buy	n/a	$41.53	-	1	Dec 23, 2024

C4 Therapeutics

Feb 23, 2026

Maintains: Buy

Price Target: $20 → $30

Current: $2.41

Upside: +1,144.81%

Exelixis

Dec 23, 2024

Initiates: Buy

Price Target: n/a

Current: $41.53

Upside: -